Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Palisade Bio (PALI) Revenue (2016 - 2023)

Palisade Bio has reported Revenue over the past 11 years, most recently at $250000.0 for Q1 2023.

  • Quarterly Revenue changed N/A to $250000.0 in Q1 2023 from the year-ago period, while the trailing twelve-month figure was $250000.0 through Dec 2023, changed N/A year-over-year, with the annual reading at $250000.0 for FY2023, N/A changed from the prior year.
  • Revenue was $250000.0 for Q1 2023 at Palisade Bio, up from $2500.0 in the prior quarter.
  • Over five years, Revenue peaked at $250000.0 in Q1 2023 and troughed at $2500.0 in Q1 2019.
  • The 3-year median for Revenue is $2500.0 (2019), against an average of $30990.4.
  • Year-over-year, Revenue tumbled 96.87% in 2019 and then skyrocketed 140.8% in 2020.
  • A 3-year view of Revenue shows it stood at $2500.0 in 2019, then changed by 0.0% to $2500.0 in 2020, then surged by 9900.0% to $250000.0 in 2023.
  • Per Business Quant, the three most recent readings for PALI's Revenue are $250000.0 (Q1 2023), $2500.0 (Q4 2020), and $2500.0 (Q3 2020).